In December 2020, BioNTech / Pfizer produced by, Covid-19 The first dose of the vaccine began to be administered in the UK. Now, a large number of vaccines have been released for emergency use around the world, and dozens of countries and regions have joined the race to vaccinate their citizens.
world Health OrganizationOne year after Turkey’s announcement of Covid-19 as a pandemic, at least 126 countries and regions in the world started the vaccination process, while Covid-19 vaccine was administered to more than 328 million people, or 4.2 percent, in the world with a population of approximately 8 billion as of yesterday. . United Nations According to the data, there are 193 countries and 2 independent regions in the world, and in 69 of them vaccination has not started yet.
Among the countries that have started vaccination, especially the European Union countries are being criticized for the slow progress in vaccination, while the vaccine supply problems of the countries are also emerging.
The European Union countries, which pay a fee for many vaccines at the development stage, both experience problems in receiving the vaccine and are in a difficult situation when the promises made are not fulfilled.
LAST EXAMPLE ASTRAZENECA
While criticisms of ‘vaccine nationalism’ were surfacing among rich and poor countries before, the vaccine crisis occurred between London and Brussels in January.
A contract was signed for 400 million doses of vaccine passed between AstraZeneca and the EU. It was announced that the EU provided a pre-financing of 336 million Euros in order to accelerate the development process of the vaccine, which is produced within the borders of the EU, in the British-Swedish partnership.
The AstraZeneca side, on the other hand, announced that it would deliver 60 percent less vaccines to the EU in January, while the EU side announced that it would receive even less vaccines than the announced, and it was stated that it would receive 25 million doses from 100 million doses to be taken.
The EU reacted to the incomplete delivery of the British-Swedish company AstraZeneca, demanding AstraZeneca to comply with its obligations, while the company argued that there was a clause in the contract to “make the utmost effort” on procurement and that it made the utmost effort to supply.
THEY CANNOT REACH THE VACCINES BROUGHT ON THEIR OWN SOIL
The vaccine crisis in Europe revealed that the future of countries depends on deliveries from companies. Germany, one of the EU countries that have difficulties in accessing vaccines produced on their own soil due to production problems, is preparing to switch to its own vaccine production as a solution.
In Germany, which wants to avoid vaccine addiction to other countries, the vaccination initiative launched by the Saxony-Anhalt regional government plans to secure the vaccines provided to Germany and to add the Covid-19 vaccine to Germany’s export items.
With the vaccine to be developed by a company called IDT Biologika and AstraZeneca, with the institution previously used as the “Anhalt Bacterial Institute” in Dessau, Germany, with a production of 30 million to 40 million doses per month from the end of 2022, at least 360 million doses per year to the EU. aims to provide vaccines.
Regarding overproduction, Reiner Haseloff, Prime Minister of Saxony-Anhalt said that he believes Germany could be a vaccine producer, just as energy companies maintain capacity during times of strong demand. used the expressions.
MANY COUNTRIES HAVE PLANS
Like Germany’s new vaccine plan, many governments around the world are planning vaccine production to prevent vaccine shortages by supporting the production of pharmaceutical companies that develop the vaccine.
Some countries, including Australia, Brazil, Japan and Thailand, form partnerships with Swedish drug manufacturer AstraZeneca to produce a Covid-19 vaccine, while Italy, one of the European countries most affected by the pandemic, announced state support for a public-private vaccine production center.
Austria, Denmark and Israel announced that they plan to allocate a joint research and development fund for the production of Covid-19 vaccine and to investigate whether they can produce their own next generation vaccines.
US GOVERNMENT: INDIA PLAYS CRITICAL ROLE
A senior executive from the US administration recently reported that India plays an important role in global Covid-19 vaccine production and that the United States, Japan and Australia are planning to help finance vaccine production capacity there.